Clinical trials: Active Nonsegmental Vitiligo

Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

• Completed
• Age: 12 years and older
• Phase 3
• Pill or oral medicine

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Trial name

Tranquillo (NCT05583526)

Testing

Ritlecitinib

Where

115 sites in United States, Australia and 13 more

Volunteers

607 people

Sponsor

Pfizer